SBI Securities
AZR

SBI Securities’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

SBI Securities’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$180 Sell
45
-2
-4% -$9 ﹤0.01% 3440
2026
Q2 		$120 Hold
47
– – ﹤0.01% 3465
2026
Q1 		$84 Buy
47
+1
+2% +$4 ﹤0.01% 3453
2025
Q4 		$255 Sell
46
-10
-18% -$81 ﹤0.01% 3135
2025
Q3 		$493 Buy
56
+3
+6% +$29 ﹤0.01% 2972
2025
Q2 		$398 Buy
53
+16
+43% +$242 ﹤0.01% 3055
2025
Q1 		$588 Hold
37
– – ﹤0.01% 2805
2024
Q4 		$946 Buy
+37
New +$963 ﹤0.01% 2633

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Abound Wealth Management
Abound Wealth Management Franklin, Tennessee $537M AUM 14.21% 1-Year Est. Return

SBI Securities's AZR Position: Q3 2026 in Review

SBI Securities reduced its Azora Therapeutics, Inc. Common Stock (AZR) stake by 4.3% in Q3 2026, selling an estimated $9 and leaving 45 shares worth $180. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

SBI Securities first reported a position in AZR in Q4 2024 and has held it in 8 quarters since. The position peaked at $946 in Q4 2024. 7 funds tracked by Wall St. Rank hold AZR as of Q3 2026.

  • SBI Securities held 45 shares of Azora Therapeutics, Inc. Common Stock worth $180 as of Q3 2026.
  • SBI Securities sold 2 Azora Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $9.
  • Azora Therapeutics, Inc. Common Stock made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3440 holding.
  • SBI Securities first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Azora Therapeutics, Inc. Common Stock position peaked at $946 in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.